» Articles » PMID: 34055667

The Role of MicroRNAs in the Infection by in Humans

Abstract

MicroRNAs are molecules belonging to an evolutionarily conserved family of small non-coding RNAs, which act on post-transcriptional gene regulation, causing messenger RNA (mRNA) degradation or inhibiting mRNA translation into proteins. These molecules represent potential biomarkers for diagnosis, non-invasive prognosis, and monitoring the development of the disease. Moreover, they may provide additional information on the pathophysiology of parasitic infections and guide strategies for treatment. The Apicomplexan parasite modifies the levels of microRNAs and mRNAs in infected host cells by modulating the innate and adaptive immune responses, facilitating its survival within the host. Some studies have shown that microRNAs are promising molecular markers for developing diagnostic tools for human toxoplasmosis. MicroRNAs can be detected in human specimens collected using non-invasive procedures. changes in the circulating host microRNAs have been associated with infection in mice and ocular toxoplasmosis in humans. Besides, microRNAs can be amplified from samples using sensitive and molecular-specific approaches such as real-time PCR. This review presents recent findings of the role that microRNAs play during infection and discuss their potential use of these small nuclei acid molecules to different approaches such as laboratory diagnosis, modulation of cell and tissue infected as other potential applications in human toxoplasmosis.

Citing Articles

Both host and parasite non-coding RNAs co-ordinate the regulation of macrophage gene expression to reduce pro-inflammatory immune responses and promote tissue repair pathways during infection with .

Sais D, Chowdhury S, Dalton J, Tran N, Donnelly S RNA Biol. 2024; 21(1):62-77.

PMID: 39344634 PMC: 11445894. DOI: 10.1080/15476286.2024.2408706.


MicroRNA mmu-miR-511-5p: A promising Diagnostic Biomarker in Experimental Toxoplasmosis Using Different Strains and Infective Doses in Mice with Different Immune States Before and After Treatment.

Mady R, El-Temsahy M, Issa Y, Zaghloul A, Khedr S Acta Parasitol. 2024; 69(2):1253-1266.

PMID: 38743178 PMC: 11182863. DOI: 10.1007/s11686-024-00851-w.


Toxoplasma gondii infection regulates apoptosis of host cells via miR-185/ARAF axis.

Su D, Zhu S, Hou Z, Hao F, Xu K, Xu F Parasit Vectors. 2023; 16(1):371.

PMID: 37858158 PMC: 10585723. DOI: 10.1186/s13071-023-05991-y.


Tryptophan metabolism and immune alterations in pregnant Hispanic women with chronic Toxoplasma gondii infection.

Prescott S, Mutka T, Baumgartel K, Yoo J, Morgan H, Postolache T Am J Reprod Immunol. 2023; 90(3):e13768.

PMID: 37641377 PMC: 10538252. DOI: 10.1111/aji.13768.


Cerebral toxoplasmosis in HIV-infected patients: a review.

Dian S, Ganiem A, Ekawardhani S Pathog Glob Health. 2022; 117(1):14-23.

PMID: 35694771 PMC: 9848325. DOI: 10.1080/20477724.2022.2083977.


References
1.
Taylor S, Barragan A, Su C, Fux B, Fentress S, Tang K . A secreted serine-threonine kinase determines virulence in the eukaryotic pathogen Toxoplasma gondii. Science. 2006; 314(5806):1776-80. DOI: 10.1126/science.1133643. View

2.
Mordue D, Monroy F, La Regina M, Dinarello C, Sibley L . Acute toxoplasmosis leads to lethal overproduction of Th1 cytokines. J Immunol. 2001; 167(8):4574-84. DOI: 10.4049/jimmunol.167.8.4574. View

3.
Platanias L . Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005; 5(5):375-86. DOI: 10.1038/nri1604. View

4.
Dubey J, Lindsay D, Speer C . Structures of Toxoplasma gondii tachyzoites, bradyzoites, and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev. 1998; 11(2):267-99. PMC: 106833. DOI: 10.1128/CMR.11.2.267. View

5.
Rosowski E, Nguyen Q, Camejo A, Spooner E, Saeij J . Toxoplasma gondii Inhibits gamma interferon (IFN-γ)- and IFN-β-induced host cell STAT1 transcriptional activity by increasing the association of STAT1 with DNA. Infect Immun. 2014; 82(2):706-19. PMC: 3911376. DOI: 10.1128/IAI.01291-13. View